The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data

Published:2024-01 Issue:1 Volume:17 Page:137-142
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Li Shanshan,Tan Yaoju,Deng Yufeng,Bai Guanghong,Huang Mingxiang,Shang Yuanyuan,Wang Yufeng,Xue Zhongtan,Zhang Xuxia,Wang Wei,Pan Junhua,Pang Yu^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference35 articles.

1. World Health Organization; 2022. Global tuberculosis report 2022. Geneva: Licence: CC BY-NC-SA 3.0 IGO.

2. Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment;Lange;Respirology,2018

3. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia;Shin;Int J Tube Lung Dis,2007

4. Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China;Xu;J Infect,2018

5. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB;Tiberi;Int J Infect Dis,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP